New study shows bivalent COVID-19 booster increases antibody response in lung cancer patients Post author: Post published:November 23, 2023 Post category:uncategorized Bivalent booster dose enhanced neutralization of Omicron XBB (sub)variants in non-small cell lung cancer (NSCLC) patients. You Might Also Like New study reveals BA.2.86 subvariant’s surprising dance with antibodies October 2, 2023 Study shows link between mobile phone use and semen quality of young men November 1, 2023 Liquid biopsies can accurately detect residual disease in patients with cervical cancer, study confirms October 3, 2023
Liquid biopsies can accurately detect residual disease in patients with cervical cancer, study confirms October 3, 2023